RIYADH — The Saudi Food and Drug Authority (SFDA) has withdrawn the Profinal pediatric suspension, which is produced by the Gulf Pharmaceutical Industries, due to a defect in the product’s quality represented in the non-conformity of a number of product batches with the approved specifications. The SFDA said this in a circular sent to all the concerned health authorities. This antipyretic, anti-inflammatory, and analgesic product bears the scientific name of Ibuprofen, of which the registration number is 74-186-98. The authority’s circular indicated that the company was obligated to withdraw the product from all beneficiary agencies, and it advised consumers to stop using the product and to see a specialist doctor to get prescribed an alternative medicine. The SFDA called on everyone to inform it of any side effects or defects in the quality of any medical products through its unified number 19999.